Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients

Rheumatology (Oxford). 2011 Feb;50(2):417-9. doi: 10.1093/rheumatology/keq218. Epub 2010 Aug 7.

Authors

Paivi M Miettunen, Aru Narendran, Aarthi Jayanthan, Edward M Behrens, Randy Q Cron

PMID: 20693540
DOI: 10.1093/rheumatology/keq218

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Child
Child, Preschool
Humans
Immunosuppressive Agents / therapeutic use*
Infant
Interleukin-1 / therapeutic use*
Macrophage Activation / drug effects*
Macrophage Activation Syndrome / drug therapy*
Male
Rheumatic Diseases / complications*
Treatment Outcome

Substances

Immunosuppressive Agents
Interleukin-1